Kgomotso Mokoala

[68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?

F. Giesel, C. Antke, M. Sathekge, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

PSMA Theranostics: Science and Practice

F. Giesel, I. Lawal, T. Lengana, 2021, Cancers.

mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis

A. Maes, C. Van de Wiele, F. Bruchertseifer, 2022, The Journal of Nuclear Medicine.

[68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?

F. Giesel, C. Antke, M. Sathekge, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

The SARS-COV-2 Seroprevalence among Oncology Patients

Amouda Venkatesan, M. Sathekge, I. Lawal, 2023, Journal of clinical medicine.

Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2

M. Sathekge, I. Lawal, M. Kgatle, 2022, BMC Cardiovascular Disorders.

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings

A. Maes, C. Van de Wiele, F. Bruchertseifer, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617

F. Bruchertseifer, I. Lawal, T. Lengana, 2019, European Journal of Nuclear Medicine and Molecular Imaging.